Skip to content
Sign in
Venture capitalBacked 1 network startup

Skybound Venture Capital

Investor with an empty profile; participated in Neurosoft Bioelectronics' oversubscribed $7.5M seed (2026).

Ticket
—Not published
Assets under management
—
Founded
—
Stages
—
Network startups backed
1
Co-investors
3most often with Connecticut Innovations

How they invest

No thesis is recorded. The only data point is the Neurosoft seed (brain-computer interfaces, EPFL spin-off), suggesting appetite for neurotechnology or frontier medtech; nothing else is documented.

Stage and ticket

Unknown; participated in a $7.5M seed.

Geography

Unknown; observed deal in Switzerland.

What makes them say yes

  • Frontier neurotech/medtech (inferred)
  • Academic spin-off with strong IP (inferred)
  • Unknown

Red flags

  • Thesis undocumented
  • Unknown

Sectors

Not published

Stages

Not published

Geographies

Not published

How to approach

Neurosoft's founders are the warm path; co-investors PL Capital, IAG Capital, Connecticut Innovations and Innosuisse also participated.

Portfolio

1 network startup · no other company

Single recorded deal.

Gaps in the portfolio

  • Thesis unknown

Network startups

  • Neurosoft BioelectronicsSWC 2026 Finalist

    EPFL spin-off making soft, stretchable cortical electrodes for minimally invasive brain interfaces, with first-in-human epilepsy data and a $7.5M seed.

    Switzerland · MedTech & devices

    • Seed (oversubscribed) · $7.5M · 1 May 2026LeadSource

Network startups that fit

3 analysed

IIT spin-off selling SiNAPS CMOS neural probes with 1,024 active electrodes for high-density brain recording, an option on brain-computer interfaces.

IIT spin-off with high-density neural probes: closest network company to Neurosoft's neural-interface field.

30%confidence

Evidence from the records

  • “Neurotechnology / neural probes”
  • “Seed”
Intro path
Neurosoft Bioelectronics founders.
First step
Ask Neurosoft how Skybound engaged.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with Connecticut Innovations, IAG Capital Partners, and PL Capital (Protocol Labs)

Sources

  1. 1tech.eu/2026/05/20/neurosoft-bioelectronics-raises-75m-for-scalable

Profile compiled from public sources. Unknown fields are left empty rather than estimated.